RavenQuest Awarded its First Cannabis Sales License from Health Canada
06 5월 2019 - 9:00PM
RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt:
1IT) (the “
Company” or
“
RavenQuest”) a federally-licensed producer of
cannabis, is pleased to announce it has secured a Health Canada
sales license at the Company’s Markham facility, also known as
“Bloomera Inc.” The license allows RavenQuest to commence sales of
both medical and recreational cannabis nationwide.
Importantly, the license allows RavenQuest to
route production from both its Markham and Edmonton facilities
through Markham, effectively allowing all RavenQuest production to
be sold through the Markham sales license.
“This is a major milestone for our company and
is a testament to the hard work and dedication of our team,” stated
George Robinson, RavenQuest CEO. “It marks the beginning of our
recreational cannabis presence as we roll out our branded product
line, Lore Cannabis™. RavenQuest’s brand will stand on the solid
foundation of science and innovation. Our focus on the plant allows
for consistent, repeatable and high-quality cannabis from our
disruptive Orbital Gardens.”
“We’ve been preparing for this day and have
maintained an active dialogue with provincial wholesalers. This
license opens the door for the next logical step of finalizing
supply agreements with provincial wholesalers as well as the
pursuit of European sales. Both our Edmonton and Markham facilities
are built to European Good Manufacturing Practices (EU GMP)
specification, and we are working vigorously toward that
certification for both facilities. It’s an exciting time at
RavenQuest as our company enters a new era – reaping the rewards of
the research, investment and hard work of the past 18 months as we
built the foundation for what is now a fully licensed and
operational cannabis company,” Robinson continued.
For more information, access RavenQuest’s
investor presentation, fact sheet and videos here.
Follow RavenQuest on Twitter
@RQBGlobal
About RavenQuest BioMed
Inc.
RavenQuest BioMed Inc. is a diversified publicly
traded cannabis company with divisions focused upon cannabis
production, management services & consulting and specialized
research & development. RavenQuest is a licensed producer with
facilities located in Markham, Ontario and Edmonton, Alberta.
RavenQuest maintains a research partnership with
McGill University focused upon cultivar (strain) recognition, plant
stabilization and yield maximization of the cannabis plant. The
Company focuses on partnerships with Indigenous communities.
On Behalf of the Board of Directors
ofRAVENQUEST BIOMED INC.
"George Robinson"Chief Executive Officer
|
|
|
For further
information, please contact: |
|
Mathieu McDonald,
Corporate Communications |
|
|
1-877-282-1586 |
|
|
|
Neither the Canadian Securities Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the Canadian Securities Exchange) accepts
responsibility for the adequacy or accuracy of this press release,
which has been prepared by management.
Cautionary Note Regarding
Forward-Looking Statements
All statements in this press release, other than
statements of historical fact, are "forward-looking information"
with respect to the Company within the meaning of applicable
securities laws, including statements with respect to anticipated
production capacity and quality. The Company provides
forward-looking statements for the purpose of conveying information
about current expectations and plans relating to the future and
readers are cautioned that such statements may not be appropriate
for other purposes. By its nature, this information is subject to
inherent risks and uncertainties that may be general or specific
and which give rise to the possibility that expectations,
forecasts, predictions, projections or conclusions will not prove
to be accurate, that assumptions may not be correct and that
objectives, strategic goals and priorities will not be achieved.
These risks and uncertainties include but are not limited to those
identified and reported in the Company’s public filings under the
Company’s SEDAR profile at www.sedar.com. Although the Company has
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward-looking information, there may be other
factors that cause actions, events or results not to be as
anticipated, estimated or intended. There can be no assurance that
such information will prove to be accurate as actual results and
future events could differ materially from those anticipated in
such statements. The Company disclaims any intention or obligation
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise unless
required by law.
RavenQuest BioMed (CSE:RQB)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
RavenQuest BioMed (CSE:RQB)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024